Skip to main content
. 2018 Dec 6;104(7):1378–1387. doi: 10.3324/haematol.2018.203018

Figure 5.

Figure 5.

Kaplan-Meier survival analysis based on pre-hematopoietic stem cell transplantation (HSCT) measurable residual disease (MRD) status and blast/plasmacytoid dendritic cell ratio (PDC). (A) Overall survival (OS) of MRD-negative (neg), MRD-positive (pos) with blast/PDC ratio <10, and MRD-pos with ratio >10 groups. (B) Relapse-free survival (RFS) of MRD-neg, MRD-pos with blast/PDC ratio <10, and MRD-pos with ratio >10 groups.